Apr 17, 2024

Featuring perspectives from Dr Joyce F Liu, Dr Mansoor Raza Mirza and Dr David M O’Malley, moderated by Dr Kathleen N Moore, including the following topics:

• Introduction (0:00)
• Current Up-Front Treatment for Advanced Ovarian Cancer (OC) — Dr Liu (2:06)
• Potential Role of Immunotherapeutic Strategies for Advanced OC...

Apr 16, 2024

Featuring a slide presentation and related discussion from Dr Kanwal Raghav, including the following topics:

• Prevalence of HER2 alterations among patients with advanced gastrointestinal tumors beyond gastroesophageal cancer (0:00)
• Dual HER2 inhibition in the treatment of HER2-amplified colorectal cancer (CRC) (4:56)

Apr 16, 2024

Featuring an interview with Dr Kanwal Raghav, including the following topics:

• Activity and tolerability of trastuzumab deruxtecan (T-DXd) in patients with HER2-expressing colorectal cancer (CRC) (0:00)
• Case: A woman in her mid 50s with multiregimen-refractory metastatic CRC receives T-DXd on a clinical trial (11:19)

Apr 12, 2024

Featuring perspectives from Dr Bita Fakhri, including the following topics:

• Overview of select presentations from ASH 2023; recent FDA approval of lisocabtagene maraleucel (0:00)
• 6-year follow-up from the Phase III CLL14 trial of first-line venetoclax/obinutuzumab versus chlorambucil/obinutuzumab for chronic lymphocytic...

Apr 8, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer | Faculty Presentation 2: Other Considerations in the Management of CRC — Arvind Dasari, MD, MS

CME information and select...